Mesosil
1 known investors
Mesosil develops a silica-based nanostructured platform (Mesosil® 500) that enables high-capacity delivery and sustained release of bioactive agents for infection prevention in medical materials. Its technology is applied to dental materials to reduce recurrent tooth decay and is under evaluation for medical devices, orthopedics, and implantable devices.
Investors · 1
Competitors · 1
by search overlapCompanies competing with Mesosil for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Mesosil do?
- Mesosil develops a silica-based nanostructured platform (Mesosil® 500) that enables high-capacity delivery and sustained release of bioactive agents for infection prevention in medical materials. Its technology is applied to dental materials to reduce recurrent tooth decay and is under evaluation for medical devices, orthopedics, and implantable devices.
- Who are Mesosil's investors?
- Mesosil's investors include GreenSky Ventures.